CN103844271A - Nutritive combination agent capable of preventing and treating dementia - Google Patents

Nutritive combination agent capable of preventing and treating dementia Download PDF

Info

Publication number
CN103844271A
CN103844271A CN201210516900.2A CN201210516900A CN103844271A CN 103844271 A CN103844271 A CN 103844271A CN 201210516900 A CN201210516900 A CN 201210516900A CN 103844271 A CN103844271 A CN 103844271A
Authority
CN
China
Prior art keywords
vitamin
dementia
brain
nutritive
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201210516900.2A
Other languages
Chinese (zh)
Inventor
孙天民
刘敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210516900.2A priority Critical patent/CN103844271A/en
Publication of CN103844271A publication Critical patent/CN103844271A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/55Linaceae (Flax family), e.g. Linum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the field of nutritional supplement agent type nutritive function food or medicine-food dual purposes, and relates to a nutritive combination agent capable of preventing and treating dementia. The nutritive combination agent capable of preventing and treating dementia is characterized by comprising powder of multiple plant extracts, an oiling agent and vitamins, is capable of providing essential nutrition and other substances for brain cells, promoting brain cells to absorb nutrition and exclude toxins very well, ensuring that brain cells and brain tissues accelerate own ability of regulation and control, and preventing symptoms such as memory loss and dementia and has a treatment effect for patients with senile dementia and parkinson disease and certain moderate and severe patients.

Description

A kind of nutrient combination agent that prevents and treats dementia
Technical field
The present invention is nutraceutical or medicine field, and the nutrient combination agent that relates to the symptoms such as prevention, treatment, rehabilitation memory loss, mistake intelligence, senile dementia, Alzheimer's disease is to have unique, Xin Ka-Wing technical characterictic;
Technical background
China has entered aging society; According to statistics, existing 6,000,000 old dementia patients of China, have become the 4th " dead killer " being only second to heart disease, cancer, apoplexy.Annual newly-increased 300,000 dull-witted sufferers, all cause very big burden to society, family, patient now.
At present, dementia is one of disease of the most normal See in elderly population, is the common disease in Lao year people Jian Kang Long longevity of harm, lacks very much good medicine now and improves the nutriment of symptom; Its main cause is that cause of disease complexity, kind are tired many, and some cause of disease finds Zhi Jin Hai No, just cannot treat and rehabilitation; Therefore, Alzheimer's disease (senile dementia) is the problem that current social is extremely urgent, and research and development related drugs and nutriment are the task of top priority.
Summary of the invention
The object of the invention is to study a kind of prevention, treatment, rehabilitation, to lose memory, lose the nutrient combination agent of the symptoms such as intelligence, senile dementia Alzheimer's disease be the deficiency that makes up current medicine, treatment technology; Especially the deficiency of preventive medicine aspect;
Senile dementia is divided into according to its cause of disease: brain degenerative disease causes that dementia is that Alzheimer's disease (being called for short AD), the cerebrovascular cause the three major types such as dementia (being called for short VaD), Mixed dementia (being called for short MixD), also has the dementia of other Different types of etiopathogenises;
Medical circle generally acknowledges that dementia pathogenesis mainly contains two kinds at present: 1, because the protein ingredient that extremely causes of amyloid lipoprotein spills cell membrane, cause neuron Xian Wei Wrapping knot and cell death; 2, relevant with the gene of apo E (APO-E4), APO-E4, when increasing the function that can resist APO-E2 or APO-E3, reduces nerve cell membrane stability, causes the fine dimension of neuron Wrapping knot and cell death;
Research and development theory of the present invention is thought:
1, because elderly brain cell can not absorb or the less absorption polyphenoils, Long phase is encroached on by free radical toxin, immunologic function is declined, thereby the protein ingredient that extremely causes of generation amyloid lipoprotein spill cell membrane, causes neuron Xian Wei Wrapping knot and cell death; The needed polyphenoils of brain cell, the present invention finds a kind of title brain flavones (polyphenoils that a kind of brain cell needs, hereinafter to be referred as brain ketone), and it is that one exists flavones in maple seed, in test application, is better than other plant flavone;
2, brain cell absorbs less than desired nutritional, especially not fertile in body is tetracosenoic acid (claiming again shark Fish acid) to the very important nervonic acid of brain cell, will in brain tissue, produce APO-E4 increases, nerve cell membrane stability is reduced, cause the fine dimension of neuron Wrapping knot and cell death;
3, brain tissue blood supply insufficiency is that brain cell absorbs less than the Important cause of disease of desired nutritional, some patient body absorption function is fair, dietary structure, appetite all can, but because abnormal (cause of disease is more) appears in brain blood supply, also can cause dementia to occur;
4, in practice, find that outside nutrition eliminating minute element that brain cell needs, wherein crucial nutrition is the not absorption of Eat and aliphatic acid and Eat and the corresponding balance of aliphatic acid, possesses Eat and fatty acid nutritive brain cell and the brain tissue of sufficient Enough with treadle-operated tilt hammer for hulling rice;
5, select brain cell, organize needed nutrient to modulate maintenance;
For this reason, the present invention has researched and developed a kind of nutrient combination agent that prevents and treats dementia, is applicable to prevention and treatment mild dementia and indivedual moderate dementia disease patient;
Measure of the present invention:
1, select maple seed extract, can be pulvis or finish, it contains rare nervonic acid is tetracosenoic acid, and it has nerve fibre reparation and dredging function, is generally acknowledged by world many countries, and various countries are further research and development;
2, it is considered herein that maple flavones is one of brain ketone, and to select Tea Polyphenols, Silver flavone be antioxidant and blood-activating formula, reach the object of removing free radical and increasing the circulation of Strong brain blood;
3, select the not grease of Eat and aliphatic acid and Eat and aliphatic acid to come balance and supplementary brain cell nutrition;
4, select vitamin C and vitamin E further to promote to remove free radical, trophic nerve system;
5, select lecithin and the linseed oil of nutrition brain tissue, especially linseed oil is containing leukotrienes, and its metabolite can impel low-density lipoprotein (LDL) to transform and raise to high density lipoprotein level (HDL), thereby reach reducing blood lipid, the object of atherosclerosis; Leukotrienes can impel free radical to decline, and is again the indispensable aliphatic acid of brain, for brain provides large energy, thereby has strengthened brain intelligence, brain is normally played a role and just can keep fit;
A kind of nutrient combination agent that prevents and treats dementia of the present invention, completes by following method:
The nutrient combination agent of a kind of prevention, treatment dementia is made up of plant extracts finish, pulvis and vitamin; Described raw material, is by weight proportion: plant extracts finish accounts for 9799%, and pulvis and vitamin account for 1-3%;
Wherein, plant extracts finish is
(1), maple seed oil 6---10%
(2), linseed oil 10---50%
(3), olive oil 1---33%
(4), lecithin oil 1-5%
(5), coconut oil 1---79%
Plant extract medicinal powder and vitamin are:
(6), plant extract medicinal powder 0.5-2.6% Tea Polyphenols and ginkgo yellow acid were by 2: 1 compositions;
(7), vitamin 0.4--0.5% vitamin C and vitamin E were by 9: 1 compositions;
Production craft step of the present invention is:
1, will meet food grade finish and pulvis (by 200 orders), raw material is weighed by weight;
2, olive oil or linseed oil are heated to 60 degrees Celsius, various pulvis are added to broad state while stirring, be incubated after two hours, filter 200 mesh sieves, remove impurity;
3, slow other various finishes Slow is injected to insulation oil and stir;
4,30,450,900g is advisable the filling one-tenth finished product of normal temperature to be down to, every bottle:;
5, root Ju conditions of patients treadle-operated tilt hammer for hulling rice is determined dose;
The present invention is further described, specific embodiment one, but the present invention is not only limited to this embodiment:
1, select to meet food grade finish and be: 98 kilograms
Wherein:
(1), 9.0 kilograms of maple seed oil
(2), 50 kilograms of linseed oil
(3), 18 kilograms, olive oil
(4), 3.0 kilograms of lecithin oil
(5), 18 kilograms of coconut oil
2, select plant extract medicinal powder and vitamin (all by 200 orders) to be: 2.0 kilograms
Wherein:
(1), 1.0 kilograms of plant extracts Tea Polyphenols
0.5 kilogram of GINKGO BILOBA EXTRACT
(2), 0.45 kilogram of vitamin vitamin C
0.05 kilogram of vitamin E
Production craft step of the present invention is:
1, will meet food grade finish and pulvis, raw material is weighed by weight;
2, olive oil or linseed oil are heated to 60 degrees Celsius, various pulvis are added to broad state while stirring, be incubated after two hours, filter 200 mesh sieves, remove impurity;
3, slow other various finishes Slow is injected to insulation oil and stir;
4, normal temperature to be down to is below 28 degrees Celsius, filling one-tenth finished product, and every bottle 30,450,900g are advisable;
5, determine dose according to conditions of patients treadle-operated tilt hammer for hulling rice.

Claims (3)

1. the nutrient combination agent of prevention, treatment dementia is to provide a brain cell nutrition, improves the trophic function food (belonging to medicine-food two-purpose product) of toxin in function of brain cell and discharge brain tissue;
It is characterized in that: the nutrient combination agent of a kind of prevention, treatment dementia is made up of plant extracts finish and pulvis and vitamin;
Described raw material is: finish accounts for 9799% that pulvis and vitamin account for 1--3% by weight proportion;
Wherein, finish is
(1), maple seed oil 6---10%
(2), linseed oil 10---50%
(3), olive oil 1---33%
(4), lecithin oil 1-5%
(5), coconut oil 1---79%
Plant extract medicinal powder and vitamin, by 200 orders be:
(6), plant extract medicinal powder 0.5-2.6%;
(7), vitamin 0.4--0.5%.
2. according to right 1 requirement, described plant extract medicinal powder is made up of by 2: 1 Tea Polyphenols and GINKGO BILOBA EXTRACT;
Described vitamin is made up of by 9: 1 vitamin C and vitamin E.
3. according to right 1 requirement, described plant extracts finish, pulvis and vitamin all reach the regulation of food-grade and food additives.
CN201210516900.2A 2012-12-06 2012-12-06 Nutritive combination agent capable of preventing and treating dementia Pending CN103844271A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210516900.2A CN103844271A (en) 2012-12-06 2012-12-06 Nutritive combination agent capable of preventing and treating dementia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210516900.2A CN103844271A (en) 2012-12-06 2012-12-06 Nutritive combination agent capable of preventing and treating dementia

Publications (1)

Publication Number Publication Date
CN103844271A true CN103844271A (en) 2014-06-11

Family

ID=50852727

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210516900.2A Pending CN103844271A (en) 2012-12-06 2012-12-06 Nutritive combination agent capable of preventing and treating dementia

Country Status (1)

Country Link
CN (1) CN103844271A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104258241A (en) * 2014-09-26 2015-01-07 洛阳华以生物工程有限公司 Health product for preventing and treating senile dementia
CN105533726A (en) * 2015-12-09 2016-05-04 南京贝杉国际贸易有限公司 Formula food supplementing omega-3 fatty acids and preventing Alzheimer's disease and preparation method thereof
CN106389740A (en) * 2016-09-13 2017-02-15 王全峰 Composition for preventing and/or delaying old people with mild cognitive impairment and use method thereof
CN106420796A (en) * 2016-12-26 2017-02-22 哈尔滨工业大学(威海) Composition for preventing or treating Alzheimer's disease
WO2017113775A1 (en) * 2015-12-29 2017-07-06 浙江旭晨医药科技有限公司 Application of triglyceride compound for use in preparing medicine for treating neurodegenerative diseases
CN109744534A (en) * 2018-12-13 2019-05-14 齐齐哈尔医学院附属第二医院 Dedicated clinical nutrition formula of Parkinsonian and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1421208A (en) * 2001-11-22 2003-06-04 中国科学院地理科学与资源研究所 Compound prepn containing alpha-linolic acid, lecithin and ginkgetin
CN1771839A (en) * 2004-11-10 2006-05-17 湖南安淳高新技术有限公司 Compound nourishing health article

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1421208A (en) * 2001-11-22 2003-06-04 中国科学院地理科学与资源研究所 Compound prepn containing alpha-linolic acid, lecithin and ginkgetin
CN1771839A (en) * 2004-11-10 2006-05-17 湖南安淳高新技术有限公司 Compound nourishing health article

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王珊珊等: "中国西部特种食用油资源开发利用状况", 《中国西部第六届营养与健康学术会议论文集》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104258241A (en) * 2014-09-26 2015-01-07 洛阳华以生物工程有限公司 Health product for preventing and treating senile dementia
CN105533726A (en) * 2015-12-09 2016-05-04 南京贝杉国际贸易有限公司 Formula food supplementing omega-3 fatty acids and preventing Alzheimer's disease and preparation method thereof
WO2017113775A1 (en) * 2015-12-29 2017-07-06 浙江旭晨医药科技有限公司 Application of triglyceride compound for use in preparing medicine for treating neurodegenerative diseases
CN106389740A (en) * 2016-09-13 2017-02-15 王全峰 Composition for preventing and/or delaying old people with mild cognitive impairment and use method thereof
CN106420796A (en) * 2016-12-26 2017-02-22 哈尔滨工业大学(威海) Composition for preventing or treating Alzheimer's disease
CN109744534A (en) * 2018-12-13 2019-05-14 齐齐哈尔医学院附属第二医院 Dedicated clinical nutrition formula of Parkinsonian and preparation method thereof

Similar Documents

Publication Publication Date Title
Changizi-Ashtiyani et al. The effects of Portulaca oleracea alcoholic extract on induced hypercholesteroleomia in rats
Nascimento et al. Effects of diet supplementation with Camu-camu (Myrciaria dubia HBK McVaugh) fruit in a rat model of diet-induced obesity
CN103844271A (en) Nutritive combination agent capable of preventing and treating dementia
CN101632655B (en) Resveratrol and bioflavonoid nutritional composition for delaying senility
Kooti et al. The effect of Halcoholic extract of celery leaves on the delivery rate (fertilization and stillbirths), the number
CN103652552A (en) Functional food with effects of reducing lipid and preventing fatty liver
Hashempour‐Baltork et al. Nutritional aspects of vegetable oils: Refined or unrefined?
Saad A review of the anti-obesity effects of wild edible plants in the mediterranean diet and their active compounds: from traditional uses to action mechanisms and therapeutic targets
CN101999652A (en) Blood fat-reducing health-care food and preparation method thereof
CN102106895B (en) Composition with function of regulating blood fat
JP2021508433A (en) Carob fruit composition and its preparation method and application
KR101784093B1 (en) Manufacturing method of composition having anti-diabetic effect containing the extracts of fermented germinated brown rice and orstachys japonia
CN112544767A (en) Preparation method of selenium-rich tabletted candy
CN102552562A (en) Formula for health care medicine capable of enhancing immunity and delaying aging
López-Chillón et al. Broccoli for food and health–research and challenges
Shivhare et al. Wonders of sesame: nutraceutical uses and health benefits
Venugopal et al. Management of diabetic dyslipidemia with subatmospheric dehydrated barley grass powder
US20120308586A1 (en) Composition based on extra virgin olive oils
Jafari et al. Performance, immune response, and oxidative status in broiler chicken fed oxidized oil and Otostgia persica leaf extract
KR101819920B1 (en) Manufacturing method of composition having anti-diabetic and anti-inflammatory effect containing the extracts of fermented germinated brown rice and cudrania tricuspidata
KR101397391B1 (en) Composition of sauce for meat including Garcinia cambogia bark extract and the method of manufacturing thereof
CN106213500A (en) A kind of Folium Nelumbinis compositions and application thereof
MM Abd EL-Rahman Therapeutic effect of leafy herbs (Camellia sinensis, Malva parviflora, Rosmarinus officinalis and Salvia officinalis) as a tool for anti-over-obesity
CN107551073A (en) Golden flower medicine food essence and preparation method thereof
KR101695299B1 (en) Composition for preventing or treating obesity or hyperlipidemia containing Piper longum extract, soy extract containing isoflavon and L-carnitin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140611